---
figid: PMC9245155__nihms-1801163-f0002
figtitle: 'Cancer Immunotherapy and Uveitis: Balancing Anti-Tumor Immunity and Ocular
  Autoimmunity'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC9245155
filename: nihms-1801163-f0002.jpg
figlink: /pmc/articles/PMC9245155/figure/F2/
number: F2
caption: Binding of BRAF inhibitors and MEK inhibitors creates blockade points in
  the MAPK pathway, inhibiting oncogenic signaling (i.e., reduced gene transcription,
  reduced cell growth and proliferation).
papertitle: 'Cancer Immunotherapy and Uveitis: Balancing Anti-Tumor Immunity and Ocular
  Autoimmunity.'
reftext: Aditya Rali, et al. Int Ophthalmol Clin. ;62(3):49-63.
year: '2023'
doi: 10.1097/IIO.0000000000000434
journal_title: International ophthalmology clinics
journal_nlm_ta: Int Ophthalmol Clin
publisher_name: ''
keywords: checkpoint inhibitor | targeted therapy | immune-related adverse events
  | VKH-like syndrome | uveitis
automl_pathway: 0.9066521
figid_alias: PMC9245155__F2
figtype: Figure
redirect_from: /figures/PMC9245155__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9245155__nihms-1801163-f0002.html
  '@type': Dataset
  description: Binding of BRAF inhibitors and MEK inhibitors creates blockade points
    in the MAPK pathway, inhibiting oncogenic signaling (i.e., reduced gene transcription,
    reduced cell growth and proliferation).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - vemurafenib
  - dabrafenib
  - trametinib
---
